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Abstract
A high sensitivity for the detection of inflammatory and destructive
changes in inflammatory joint diseases makes magnetic resonance
imaging potentially useful for assigning specific diagnoses, such as
rheumatoid arthritis and psoriatic arthritis in arthritides, that remain
undifferentiated after conventional clinical, biochemical and
radiographic examinations. With recent data as the starting point,
the present paper describes the current knowledge on magnetic
resonance imaging in the differential diagnosis of undifferentiated
arthritis.
Introduction
The potential advantage of using magnetic resonance
imaging (MRI) in the differential diagnosis of undifferentiated
arthritis is evident. Earlier diagnosis and appropriate therapy
have been recognized as essential factors for improved
clinical outcomes in early rheumatoid arthritis (RA) [1]. MRI is
known to be more sensitive than conventional clinical
examination and radiography for the detection of inflammatory
and destructive joint changes. But is there a scientific basis
for the use of MRI in the differential diagnostic process?
Sensitive visualization of early changes
Numerous studies have shown that MRI allows the detection of
RA bone erosions earlier than conventional radiography allows,
and there is solid evidence that MRI bone oedema and bone
erosions have predictive value with respect to subsequent
radiographic progression [2]. Correspondingly, MRI is more
sensitive than clinical examination for the detection of
inflammatory soft tissue changes such as synovitis,
tenosynovitis and enthesitis [2-6]. Comparisons with mini-
arthroscopy and histopathological findings have documented
that MRI synovitis, as determined by contrast-enhanced T1-
weighted MRI, represents true synovial inflammation [7,8].
Different findings in different arthritides
Differences between MRI findings in peripheral joints of
different arthritides, mainly RA and psoriatic arthritis, have
been investigated. In a previous issue of Arthritis Research
and Therapy, Cimmino and colleagues describe an
interesting, although unsuccessful, approach to differentiate
between psoriatic arthritis and RA using dynamic MRI [9].
The lack of success is probably not surprising because their
method takes into account only enhancement rates after
intravenous contrast injection and not the anatomical
information provided by the location of the inflammatory
changes on MRI. The well-known problems with reliability and
reproducibility of measuring enhancement in small, visually
selected, circular regions of interest [8,10], as in the study by
Cimmino and colleagues, may also contribute.
Earlier attempts have incorporated anatomic information.
Small studies have shown that MRI signs of inflammation in
RA are more frequent in the synovial membrane than at the
insertions of ligaments and tendons (enthesitis), while the
opposite is true for seronegative spondyloarthritides such as
psoriatic arthritis [3,4,11]. This is in accordance with the
clinical experience that entheseal/capsular changes are more
prominent in, but are not exclusively occurring in, sero-
negative spondyloarthritides. Preliminary results from a recent
MRI study by Boutry and colleagues of patients with RA,
systemic lupus erythematosus and primary Sjogren’s
syndrome suffering from hand polyarthralgias found a
frequency of metacarpophalangeal-joint bone oedema of
71% in RA patients versus 5% in non-RA patients, but no
RA-specific findings were revealed [12].
A report from an early arthritis clinic [5] suggested that early
MRI erosions only occurred in patients fulfilling the American
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College of Rheumatology (ACR) 1987 revised criteria for RA
at baseline or within the subsequent year. However, MRI
bone erosions have also been found in other inflammatory
arthritides [13].
Some types of pathology and their corresponding MRI
findings are thus markedly more frequent in RA than in other
arthritides, but are still not pathognomonic.
Interestingly, Cimmino and colleagues [9] used a low-field
dedicated extremity MRI unit, and not a conventional high-
field MRI unit as used in the majority of studies. Extremity MRI
has, due to reduced costs and patient discomfort, a major
potential for use in rheumatological clinical practice.
However, more validation is needed.
Value in the differential diagnosis of
undifferentiated arthritis
Definite answers concerning the differential diagnostic value
of MRI should obviously be achieved through longitudinal
studies of patients with undifferentiated arthritis. Studies of
this kind are scarce.
In small studies it has been suggested that the
incorporation of MRI signs of synovitis in the ACR criteria
for RA would increase their accuracy, leading to an earlier
diagnosis of some RA patients [6,14]. A retrospective study
by Sugimoto and colleagues found that including
“periarticular enhancement in at least one wrist or finger
joint” as a third criterion in the classification tree format of
the ACR 1987 criteria increased the sensitivity and
accuracy of the diagnosis of RA. However, there were also
false-positive cases [14]. In a subsequent study, early
polyarthritis patients suspected for early RA were examined
prospectively, with clinical follow-up diagnoses as the ‘gold
standard’ reference [6]. Inclusion of the MRI criterion
‘bilateral joint enhancement’ increased the baseline
sensitivity for RA from 77% to 96% and increased the
diagnostic accuracy from 83% to 94%, but the inclusion
decreased the specificity from 91% to 86% [6]. These
findings have not been retested on other cohorts.
In a recent Danish study (Duer, Østergaard, Vallø, Hørslev-
Petersen, unpublished data) the value of hand MRI and
whole-body bone scintigraphy in the differential diagnosis of
patients with unclassified polyarthritis was investigated in
clinical practice. Forty-one patients with polyarthritis (≥2
swollen joints; >6 months’ duration), which remained
unclassifiable despite conventional clinical, biochemical and
radiographic (hands and feet) examinations, were included.
Patients who fulfilled the ACR criteria for RA or who had
radiographic bone erosions were excluded. Contrast-
enhanced MRI, using a 0.2-Tesla dedicated extremity MRI
unit (Artoscan, Esaote, Italy), of the wrist and metacarpo-
phalangeal joints of the most symptomatic hand and whole-
body bone scintigraphy were performed. The patterns of
joint involvement were noted. Patterns considered
compatible with RA were as follows: for MRI erosion and
MRI synovitis, joints other than the first carpometacarpal
joints; and for scintigraphy, several joints but not the distal
interphalangeal and first carpometacarpal joints.  Sub-
sequently, two rheumatologists agreed on the most probable
diagnosis and patients were treated accordingly. A final
diagnosis was made by another specialist review 2 years
later.
Tentative diagnoses in this unpublished Danish study after
MRI and bone scintigraphy were 13 patients with RA, eight
patients with osteoarthritis, 11 patients with other inflam-
matory diseases and nine patients with arthralgias without
inflammatory or degenerative origin. Two years later, 11 of
13 patients with an original tentative RA diagnosis had
fulfilled the ACR criteria, while two patients were reclassified
(one to psoriatic arthritis [erosive arthritis, rheumatoid factor-
negative and psoriasis] and one to unspecific self-limiting
arthritis). No patients classified as non-RA at baseline had
fulfilled the ACR criteria after 2 years. The positive and
negative predictive value of having MRI synovitis, MRI
erosion and scintigraphic patterns compatible with RA were
1.00 and 0.87, respectively. Thus, in polyarthritis patients
unclassified despite conventional clinical, biochemical and
radiographic examinations, MRI and scintigraphy allowed
correct classification as RA or non-RA in 39 of 41 patients,
when fulfilment of ACR criteria 2 years later was considered
the standard reference (Duer and colleagues, unpublished
data).
In future studies of undifferentiated arthritis the value of MRI
should be compared with the contributions of other potential
diagnostic determinants, such as rheumatoid factor, anti-
cyclic citrullinated peptide antibody, clinical/biochemical
disease activity measures, radiographic erosions and
promising biomarkers; for example, comparison by logistic
regression analysis with the aim to develop the best possible
prediction model, as previously done (without incorporating
MRI) by Visser and colleagues [15].
Conclusion
MRI is more sensitive for the detection of early inflammatory
and destructive changes in inflammatory arthritides than are
conventional methods. MRI may be valuable for diagnosing
specific arthritides, including early RA, in patients with
undifferentiated arthritides, but the sensitivity and specificity,
and so on, of MRI are not yet known. Even though MRI will
probably only rarely be able to assign specific diagnoses
alone, it can be a very useful addition to the differential
diagnostic process. Our current knowledge strongly
encourages further testing in patients with early suspected or
unclassified arthritis.
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